Clinical studies recruiting near Xiamen

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorec
Phase 2 · The First Affiliated Hospital of Xiamen University · Fudan University · NCT06521866 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Local Institution - 0056 · Bristol-Myers Squibb · NCT07106762 BM Shockwave Devices Clinical Study in Coronary Calcified Lesions
NA · BrosMed Medical Co., Ltd · NCT07010094 Indomethacin vs Diclofenac for Preventing PEP
NA · Department of Gastroenterology, Hongai Hospital · Air Force Military Medical University, China · NCT07071441 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · The First Affiliated Hospital of Xiamen University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169 PulseSelect™ PFA Global Registry
Phase N/A · The First Affiliated Hospital of Xiamen University · Medtronic Cardiac Ablation Solutions · NCT06393920 GPC3-Targeted PET/CT in Hepatocellular Carcinoma
NA · The First Affiliated Hospital of Xiamen University · The First Affiliated Hospital of Xiamen University · NCT07677774 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Zhongshan Hospital Affiliated to Xiamen University · Boehringer Ingelheim · NCT07355296 Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC
Phase 2 · The First Affiliated Hospital of Xiamen University · Guangdong Association of Clinical Trials · NCT05536505 Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma
Phase 2 · Bing Xu · The First Affiliated Hospital of Xiamen University · NCT06826118 Rectal NSAIDs With/Without PD Stent for PEP Prevention
NA · Department of Gastroenterology, Fujian Medical University Xi · Air Force Military Medical University, China · NCT07117318 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · The First Affiliated Hospital of Xiamen University · Takeda · NCT06671496 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · The First Affiliated Hospital of Xiamen University · Shanghai Henlius Biotech · NCT07160335 Nudge-Based Shared Decision Making and Self-Management in Type 2 Diabetes: A Randomized Trial
NA · Xiang'an Hospital Affiliated to Xiamen University · Yunxuan Li · NCT07129915 VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (
Phase 2 · Bing Xu · The First Affiliated Hospital of Xiamen University · NCT05603884 T-cell Developmental Status in Patients With Malignant Hematological Tumors
Phase N/A · Zhijuan Lin · The First Affiliated Hospital of Xiamen University · NCT07035938 A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Phase 2 · Zhongshan Hospital Affiliated to Xiamen University · Eli Lilly and Company · NCT07483099 Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted PET/CT in Recurrent and Metastatic Thyroid Cancer
NA · The First Affiliated Hospital of Xiamen University, Xiamen, · The First Affiliated Hospital of Xiamen University · NCT07753499 Clinical Evaluation of 177Lu-AB-3PRGD2 in Various Solid Tumors With Integrin αvβ3 Positive Expression
Phase 1 · The First Affiliated Hospital of Xiamen University · The First Affiliated Hospital of Xiamen University · NCT06375564 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · The First Affiliated hospital of Xiamen University-oncology · Turning Point Therapeutics, Inc. · NCT03093116 AZA Combined With RCHOP in P53-mutated DLBCL.
Phase 2 · Bing Xu · The First Affiliated Hospital of Xiamen University · NCT06158399 ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
Phase 2 · The First Affiliated Hospital of Xiamen University · Zenith Epigenetics · NCT04986423 A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
Phase 1/Phase 2 · The First Affiliated Hospital of Xiamen University · RemeGen Co., Ltd. · NCT07105215 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0237 · Celgene · NCT05519085 A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1
Phase 1/Phase 2 · Research site05 · Allist Pharmaceuticals, Inc. · NCT05276726 Safety and Pharmacokinetics of NM6603 in Chinese Patients With Advanced Solid Tumors
Phase 1 · The First Affiliated Hospital of Xiamen University · NucMito Pharmaceuticals Co. Ltd. · NCT07292038 Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study)
NA · Xiamen Cardiovascular Hospital · Hangzhou Endonom Medtech Co., Ltd. · NCT06385379 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Xiamen Cardiovascular Hospital Xiamen University · Boehringer Ingelheim · NCT06531824 China HeadAche DIsorders RegiStry
Phase N/A · The First Affiliated Hospital of Xiamen University · Beijing Tiantan Hospital · NCT05334927 A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Soli
Phase 1 · The First Affiliated Hospital of Xiamen University · BeOne Medicines · NCT07181681

Look up another city

Look up another condition